Gene · 9788
MTSS1: MTSS I-BAR domain containing 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. MTSS1: MTSS I-BAR domain containing 1. Genes, record 9788. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/9788
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| O43312 | Protein MTSS 1 | 755 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents26
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| WO 2026127113 A | 2026-06-18 | 12 | O43312 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 15191 | O43312 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 7442 | O43312 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 15191 | O43312 | Espacenet |
| JP 2025512333 A | 2025-04-17 | 825 | O43312 | Espacenet |
| JP 2025032204 A | 2025-03-11 | 31878 | O43312 | Espacenet |
| KR 1020250017231 A | 2025-02-04 | 7442 | O43312 | Espacenet |
| EP 4461818 A2 | 2024-11-13 | 31878 | O43312 | Espacenet |
| JP 2024123008 A | 2024-09-10 | 6969 | O43312 | Espacenet |
| JP 2023058610 A | 2023-04-25 | 31878 | O43312 | Espacenet |
1 to 10 of 26
See all 26 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants960
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | MTSS1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 5 | 2025 |
| R01AR046786 | Stromal Regulation of Basal Cell Carcinoma Formation | 5 | 2025 |
| T32CA009302 | Leveraging innovative technologies in basic and clinical cancer research | 5 | 2025 |
| R01GM073791 | Structural-Functional Basis of Actin Cytoskeleton Dynamics | 3 | 2025 |
| R01HL141232 | MTSS1 in myocardial disease | 3 | 2025 |
| TL1TR001880 | NRSA Training Core | 3 | 2025 |
| ZIAHG000215 | Human Biochemical Genetics | 3 | 2025 |
| P30CA006516 | Dana-Farber/Harvard Cancer Center | 2 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 2 | 2025 |
| P30CA033572 | Cancer Center Support Grant | 2 | 2025 |
1 to 10 of 960Source NIH's project files
See all 960 nih grantsPapers1,348
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A potential new biomarker in lip cancer: Metastasis suppressor protein 1 (MTSS1). | Arch Oral Biol | 2026 | 42777454 | PubTator, text mining | PubMed |
| Rescue of pATOM36-depleted T. brucei by human MTCH1/2 reveals common features of protein insertases. | FEBS J | 2026 | 42740487 | PubTator, text mining | PubMed |
| GWAS meta-analysis provides new insights into uveal melanoma risk. | Br J Cancer | 2026 | 42303830 | PubTator, text mining | PubMed |
| Glycogenin-1 deficiency: a case report and review of the literature. | Front Genet | 2026 | 42294501 | PubTator, text mining | PubMed |
| MTSS1-dependent ubiquitin modifications mediated by FBXO44 remodel the actin cytoskeleton to promote gastric cancer progression. | Mol Cancer | 2026 | 41998764 | PubTator, text mining | PubMed |
| Genetic Variants Associated with Life Expectancy in Patients with Chagas Disease. | Med Sci (Basel) | 2026 | 41892852 | PubTator, text mining | PubMed |
| Modulation of Inflammatory and Oxidative Stress Pathways in COPD: Unraveling the Mechanisms of Fenugreek Through Network Pharmacology and Single-Cell RNA Sequencing. | Int J Chron Obstruct Pulmon Dis | 2026 | 41808731 | PubTator, text mining | PubMed |
| Comparative Analysis of Methodological Aspects of the Study of Extracellular Vesicles and Extracellular Mitochondria: From Isolation to Internalization. | Curr Issues Mol Biol | 2026 | 41751479 | PubTator, text mining | PubMed |
| CCL11 promotes hepatocellular carcinoma recurrence after surgery by potentiating immunosuppressive CCR5 + CD206 + M2-like macrophages and promoting tumor invasiveness. | Cell Death Dis | 2026 | 41714328 | PubTator, text mining | PubMed |
| Genomic structural equation modeling reveals shared genetic structure of cardiac function and structure-function association studies of CLCNKA mutations. | Sci Rep | 2026 | 41605996 | PubTator, text mining | PubMed |
1 to 10 of 1,348
See all 1,348 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/9788
GET https://conductscience.org/api/genes/v1/9788/patents?page=2